Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women

Obstetrics and Gynecology

Volumn 90, Issue 1, 1997, Pages 22-25

  Wakatsuki, Akihiko ^a   Ikenoue, Nobuo ^a   Sagara, Yusuke ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ESTROGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; POSTMENOPAUSE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS; CHOLESTEROL; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; LIPOPROTEINS, LDL; MIDDLE AGED; PARTICLE SIZE; POSTMENOPAUSE; TRIGLYCERIDES;

EID: 0030905777     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00140-3     Document Type: Article

References (26)

1. Castelli W. Epidemiology of coronary heart diseases: The Framingham Study. Am J Med 1984;76:4-12.
2. Kannel WB. Metabolic risk factors for coronary artery disease in women: Prospective from the Framingham Study. Am Heart J 1987;114:413-9.
3. Wakatsuki A, Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol 1995;85: 523-8.
4. Arca M, Vega GL, Grundy SM. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. JAMA 1994;271:453-9.
5. Shen MM, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal human subjects. J Lipid Res 1981;22:236-44.
6. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low-density lipoprotein subclasses patterns and the risk of myocardial infarction. JAMA 1988;260:1917-21.
7. Campos H, MacNamara JR, Wilson PWF, Ordovas JM, Schaefer EJ. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988;67:30-5.
8. Wakatsuki A, Sagara Y. Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen. Maturitas 1996;25:35-44.
9. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204.
10. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with changes in plasma triglyceride concentration. Arterioscler Thromb 1992;12:1284-90.
11. Bautovich GJ, Dash MJ, Hensley WJ, Turtle JR. Gradient gel electrophoresis of human plasma lipoproteins. Clin Chem 1973;19: 415-8.
12. Allain CC, Poon LS, Chan CG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
13. Ikeda T, Shibuya Y, Senba U, Sugiuchi H, Araki S, Uri J, et al. Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radical immunodiffusion assays. J Clin Lab Anal 1991;5:90-5.
14. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human plasma. J Clin Invest 1955;34:1346-53.
15. Gambert P, Bouzenard-Gambert C, Athias A, Farnier M, Lallemant C. Human low density lipoprotein subfractions separated by gradient gel electrophoresis: Composition, distribution, and alterations induced by cholesteryl ester transfer protein. J Lipid Res 1990;31:1199-210.
16. Lagrost L, Gandjini H, Athias A, Dangremont V, Lallemant C, Gambert P. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb 1993;13:815-25.
17. Austin MA, King MC, Vranizan KM, Newman B, Krauss RM. Inheritance of low-density lipoprotein subclass patterns: Results of complex segregation analysis. Am J Hum Genet 1988;43:838-46.
18. Ma PT, Yamamoto T, Goldstein JT, Brown MS. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha ethinyl estradiol. Proc Natl Acad Sci U S A 1986;83:792-6.
19. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991;32:1741-53.
20. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992;93:189-99.
21. Lagrost L, Gambert P, Lallemant C. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 1994;14:1327-36.
22. Shen BM, Scanu AM, Kezdy FJ. Structure of human serum lipoproteins inferred from compositional analysis. Proc Natl Acad Sci U S A 1977;74:837-41.
23. Deckelbaum RJ, Eisenberg S, Oschry Y, Butbul E, Sharon I, Olivecrona T. Reversible modification of human plasma low density lipoproteins toward triglyceride-rich precursors. J Biol Chem 1982;257:6509-17.
24. Campos H, Sacks FM, Walsh BW, Schiff I, Ohanesian MA, Krauss RM. Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 1993; 42:1153-8.
25. Slone D, Shapiro S, Kaufman DW, Rosenberg L, Miettinen OS, Stolley PD. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N Engl J Med 1981;305: 420-4.
26. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal estrogen therapy and protection from ischemic heart disease. Lancet 1981;1:858-60.